澳门永利yl6776 - 澳门永利手机登录官网

科研成果

论文题目:	Characterization of Periplasmic Protein BP26 Epitopes of Brucella melitensis Reacting with Murine Monoclonal and Sheep Antibodies
作者:	Qiu, JL; Wang, WJ; Wu, JB; Zhang, H; Wang, YZ; Qiao, J; Chen, CF; Gao, GF; Allain, JP; Li, CY
联系作者:	Qiu, JL
刊物名称:	PLOS ONE
期:	3
卷:	7
页:
年份:	2012
影响因子:	4.092
论文下载:	下载地址
摘要:	More than 35,000 new cases of human brucellosis were reported in 2010 by the Chinese Center for Disease Control and Prevention. An attenuated B. melitensis vaccine M5-90 is currently used for vaccination of sheep and goats in China. In the study, a periplasmic protein BP26 from M5-90 was characterized for its epitope reactivity with mouse monoclonal and sheep antibodies. A total of 29 monoclonal antibodies (mAbs) against recombinant BP26 (rBP26) were produced, which were tested for reactivity with a panel of BP26 peptides, three truncated rBP26 and native BP26 containing membrane protein extracts (NMP) of B. melitensis M5-90 in ELISA and Western-Blot. The linear, semi-conformational and conformational epitopes from native BP26 were identified. Two linear epitopes recognized by mAbs were revealed by 28 of 16mer overlapping peptides, which were accurately mapped as the core motif of amino acid residues (93)DRDLQTGGI(101) (position 93 to 101) or residues (104)QPIYVYPD(111), respectively. The reactivity of linear epitope peptides, rBP26 and NMP was tested with 137 sheep sera by ELISAs, of which the two linear epitopes had 65-70% reactivity and NMP 90% consistent with the results of a combination of two standard serological tests. The results were helpful for evaluating the reactivity of BP26 antigen in M5-90.